In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway

The Journal of Clinical Investigation
M C JongL M Havekes

Abstract

To study the role of apoC1 in lipoprotein metabolism, we have generated transgenic mice expressing the human APOC1 gene. On a sucrose-rich diet, male transgenic mice with high APOC1 expression in the liver showed elevated levels of serum cholesterol and triglyceride compared with control mice (5.7+/-0.7 and 3.3+/-2.1 vs. 2.7+/-0.1 and 0.4+/-0.1 mmol/liter, respectively). These elevated levels were mainly confined to the VLDL fraction. Female APOC1 transgenic mice showed less pronounced elevated serum lipid levels. In vivo VLDL turnover studies revealed that, in hyperlipidemic APOC1 transgenic mice, VLDL particles are cleared less efficiently from the circulation as compared with control mice. No differences were observed in the hepatic production and extrahepatic lipolysis of VLDL-triglyceride. Also, VLDL isolated from control and APOC1 transgenic mice were found to be equally good substrates for bovine lipoprotein lipase in vitro. These data indicate that the hyperlipidemia in APOC1 transgenic mice results primarily from impaired hepatic VLDL particle clearance, rather than a defect in the hydrolysis of VLDL-triglyceride. To investigate which hepatic receptor is involved in the apoC1-mediated inhibition of VLDL clearance, APOC...Continue Reading

References

Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R C KowalM S Brown
Jan 31, 1972·Biochemical and Biophysical Research Communications·W V Brown, M L Baginsky
May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·T E WillnowJ Herz
Apr 1, 1995·Current Opinion in Lipidology·J Herz, T E Willnow
Apr 1, 1994·The Journal of Clinical Investigation·B J van VlijmenL M Havekes
Apr 1, 1994·The Journal of Clinical Investigation·N S ShachterJ L Breslow
Oct 1, 1993·Genomics·M J HofferR R Frants
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J Herz, R D Gerard
Oct 1, 1995·Current Opinion in Lipidology·R J Havel
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER

❮ Previous
Next ❯

Citations

May 22, 2003·Progress in Biophysics and Molecular Biology·Victor Martin Bolanos-Garcia, Ricardo Nunez Miguel
Apr 21, 1999·Progress in Lipid Research·D A Chappell, J D Medh
May 19, 2001·European Journal of Biochemistry·B W AtcliffeG J Howlett
Feb 11, 2005·Omics : a Journal of Integrative Biology·Eugene DavidovStephen Naylor
May 16, 2001·Current Opinion in Lipidology·P J TackenK W van Dijk
May 16, 2001·Current Opinion in Lipidology·N S Shachter
Nov 17, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Carlos O MendivilFrank M Sacks
Feb 14, 1998·The Journal of Clinical Investigation·M C JongL M Havekes
May 19, 2005·Clinical Chemistry and Laboratory Medicine : CCLM·Kristiaan WoutersMarten H Hofker
Feb 11, 2005·Applied Bioinformatics·Matej OresicThomas Plasterer
Jul 28, 2015·Expert Opinion on Therapeutic Targets·Thomas GautierLaurent Lagrost
Mar 1, 2007·Journal of Clinical Lipidology·William Virgil Brown
Jul 25, 2009·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Takeshi InagakiJuro Sakai
Sep 11, 1999·The Journal of Laboratory and Clinical Medicine·M Belalcazar, L Chan
Nov 11, 2008·Biochemical and Biophysical Research Communications·Willeke de HaanPatrick C N Rensen
Dec 16, 2016·The Journal of Pathology·Pascal BusHans J Baelde
Dec 4, 2004·Journal of Lipid Research·Jimmy F P BerbéePatrick C N Rensen
Dec 28, 2007·Journal of Lipid Research·Karlygash AbildayevaMonique Mulder
Oct 3, 2003·Journal of Lipid Research·Martin MuurlingPeter J Voshol
Oct 29, 2002·Journal of Lipid Research·Jessica LieArie van Tol
Nov 28, 2002·Journal of Lipid Research·Karin Conde-KnapeNeil S Shachter
Oct 5, 2002·Journal of Lipid Research·Jeffrey S CohnJean Davignon
Mar 7, 2007·Journal of Lipid Research·Marit WesterterpPatrick C N Rensen

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.